A detailed history of Frisch Financial Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Frisch Financial Group, Inc. holds 2,487 shares of ABT stock, worth $284,090. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,487
Holding current value
$284,090
% of portfolio
0.09%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $248,874 - $293,789
2,487 New
2,487 $284,000
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $72,830 - $80,438
-665 Reduced 26.21%
1,872 $213,000
Q4 2023

Feb 12, 2024

BUY
$90.19 - $110.4 $721 - $883
8 Added 0.32%
2,537 $279,000
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $241,595 - $289,873
2,529 New
2,529 $245,000
Q1 2023

May 11, 2023

BUY
$96.86 - $114.01 $2,421 - $2,850
25 Added 0.85%
2,952 $299,000
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $40,780 - $47,842
429 Added 17.17%
2,927 $321,000
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $52,540 - $60,832
543 Added 27.77%
2,498 $242,000
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $816 - $986
8 Added 0.41%
1,955 $212,000
Q1 2022

May 10, 2022

BUY
$114.02 - $139.04 $684 - $834
6 Added 0.31%
1,947 $231,000
Q4 2021

Feb 09, 2022

SELL
$115.53 - $141.46 $22,412 - $27,443
-194 Reduced 9.09%
1,941 $273,000
Q3 2021

Nov 16, 2021

BUY
$116.66 - $129.06 $249,069 - $275,543
2,135 New
2,135 $252,000
Q3 2021

Nov 10, 2021

SELL
$116.66 - $129.06 $271,584 - $300,451
-2,328 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$105.79 - $124.53 $30,255 - $35,615
286 Added 14.01%
2,328 $270,000
Q1 2021

May 13, 2021

BUY
$108.84 - $128.23 $9,033 - $10,643
83 Added 4.24%
2,042 $245,000
Q4 2020

Jan 26, 2021

BUY
$105.0 - $114.42 $735 - $800
7 Added 0.36%
1,959 $214,000
Q3 2020

Nov 10, 2020

BUY
$91.64 - $111.29 $178,881 - $217,238
1,952 New
1,952 $212,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Frisch Financial Group, Inc. Portfolio

Follow Frisch Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frisch Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Frisch Financial Group, Inc. with notifications on news.